3 Reasons Investors Love Insulet (PODD) Over the past six months, Insulet has been a great trade. While the S&P 500 was flat, the stock price has climbed by 14.6% to $265.87 per share. This was ...

Over the past six months, Insulet has been a great trade. While the S&P 500 was flat, the stock price has climbed by 14.6% to $265.87 per share. This was partly due to its solid quarterly results, and ...

On the type 1 diabetes front, Insulet Corp.’s RADIANT study demonstrated massive improvement in time in range as well as lower glycemic levels for patients switching from multiple injections to the ...

Shares of Insulet Corp. PODD slipped 1.74% to $260.27 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.33% to 5,693.31 ...

Insulet Trading Down 0.5 % Shares of Insulet stock opened at $272.71 on Wednesday. Insulet Co. has a twelve month low of $160.19 and a twelve month high of $289.46. The company has a quick ratio ...

Insulet is celebrating a jury's verdict that rival South Korean firm EOFlow stole trade secrets relating to its wearable insulin pump technology.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...